PATENT CLAIM ANALYSIS

Application Number: 15764264
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["546", "209000"]

Abstract:
Problem to be Solved There is a need for a new antibiotic having a novel mechanism of action which exhibit strong antibacterial activity not only against sensitive bacteria but also against resistant bacteria thereof, and at the same time possesses excellent solubility an a safety profile amenable to human use. Solution to the Problem As a result of intensive research, the present inventors have found that a compound represented by general formula (I), a stereoisomer, or a pharmaceutically acceptable salt thereof inhibits DNA gyrase GyrB subunit and/or topoisomerase IV ParE subunit possesses excellent solubility and a safety profile for use in humans for the treatment of bacterial infectious diseases.

Claim (Index 3):
The compound, a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof according to  claim 1 , wherein R represents methyl or ethyl.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 90.0
- Lexical Diversity: 1.39286
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15547776', '15262112', '12187115', '11884923', '15314562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8195649626002941
- 35 USC 102 Novelty (BERT): 0.5103628123100238
- Combined Prediction Score: 0.788644747571267
- Mean Citation Score: 296.5449680000001
- Max Citation Score: 311.3937
- Similarity Product: 252.7532321746052

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test